Form 8-K - Current report:
SEC Accession No. 0001193125-22-225367
Filing Date
2022-08-19
Accepted
2022-08-19 16:31:09
Documents
14
Period of Report
2022-08-19
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d371366d8k.htm   iXBRL 8-K 30001
2 EX-99.1 d371366dex991.htm EX-99.1 9046
6 GRAPHIC g371366dsp4.jpg GRAPHIC 12747
  Complete submission text file 0001193125-22-225367.txt   182189

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA amrn-20220819.xsd EX-101.SCH 2866
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE amrn-20220819_lab.xml EX-101.LAB 18690
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE amrn-20220819_pre.xml EX-101.PRE 11693
8 EXTRACTED XBRL INSTANCE DOCUMENT d371366d8k_htm.xml XML 3878
Mailing Address SPACES SOUTH DOCKLANDS, BLOCK C 77 SIR JOHN ROGERSON'S QUAY DUBLIN 2 L2 D02 VK60
Business Address SPACES SOUTH DOCKLANDS, BLOCK C 77 SIR JOHN ROGERSON'S QUAY DUBLIN 2 L2 D02 VK60 353 1 6699 020
AMARIN CORP PLC\UK (Filer) CIK: 0000897448 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-21392 | Film No.: 221181253
SIC: 2834 Pharmaceutical Preparations